Lobe Sciences Ltd.
LOBEF
$0.0176
-$0.0043-19.64%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.78% | -40.65% | 7.49% | 50.89% | 63.44% |
| Total Depreciation and Amortization | -71.64% | -20.42% | 91.41% | 267.73% | 693.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.88% | -43.75% |
| Total Other Non-Cash Items | 586.03% | 564.51% | 78.96% | -92.94% | -90.00% |
| Change in Net Operating Assets | -58.26% | -39.51% | -13.05% | 7.05% | 202.91% |
| Cash from Operations | -290.80% | 22.56% | 73.53% | 36.18% | 92.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1,010.00% | 67.21% | 67.21% | 0.24% | -75.19% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -99.20% | -99.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | 1,339.19% | 53.31% | -41.41% | -78.56% | -96.65% |
| Foreign Exchange rate Adjustments | -151.43% | 944.44% | -380.00% | -161.54% | -683.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.33% | 95.06% | 112.24% | -906.86% | 81.72% |